Insight

May 6, 2024, 15:45

Myeloma Paper of the Day, May 6th, suggested by Robert Orlowski

Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X:

“Myeloma Paper of the Day: Study of impact of presence and number of chromosomal abnormalities on clinical outcomes in Waldenström macroglobulinemia finds correlation with inferior PFS and OS regardless of the type of single chromosome aberration.”

Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience

Authors: Nicolò Danesin, Laura Bonaldi, Annalisa Martines, Silvia Nalio, Roberta Bertorelle, Sofia Compagno, Raffaella Marcato, Sabrina Manni, Federico Scarmozzino, Marco Pizzi, Angelo Paolo Dei Tos, Alessandro Cellini, Greta Scapinello, Andrea Visentin, Livio Trentin, and Francesco Piazza.

Myeloma Paper of the Day

Source: Robert Orlowski/X

Alessandro Cellini Andrea Visentin Angelo Paolo Dei Tos Annalisa Martines cancer chromosomal abnormalities Federico Scarmozzino Francesco Piazza Greta Scapinello Laura Bonaldi Livio Trentin Marco Pizzi MD Anderson Cancer Center Myeloma Paper of the Day Nicolò Danesin OncoDaily Oncology Raffaella Marcato Robert Orlowski Roberta Bertorelle Sabrina Manni Silvia Nalio Sofia Compagno Waldenström macroglobulinemia

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage